Atox Bio Ltd
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury (NCT03403751) | Atox Bio Ltd | 2018-05-24 |
Track Atox Bio Ltd automatically
Every clearance here is in the API, with alerts when new ones post.